Tag: healthcare
Dual Therapy Shifts SMA Treatment Landscape
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments...
New Treatment Slows Brain Tumor Regrowth
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
New Guidelines for Stroke Rehabilitation Released
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...
Sarkey Highlights Oveporexton Impact on Type 1 Narcolepsy
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn...
FDA Week: New CMT Trial Framework and Brain Injury Medicine Focus
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...
Botox Expands Use to Migraine and Spasticity
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing...
FDA approves Avulux lenses for migraine photophobia
FDA approval of Avulux migraine lenses offers an over‑the‑counter solution to reduce photophobia for migraine...
FDA Halts RGX-121 Gene Therapy for MPS II
Gene therapy MPS II stalls as the FDA places a clinical hold on RGX-121 after...
Factor XIa Inhibitors Show Promise in Stroke Prevention
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering...
FDA Approves New Treatments for Brain Disorders
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam...